DexCom, Inc. (DXCM)
USD 59.82
(-3.2%)
USD 59.82
(-3.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.57 Billion USD | 99.09% |
| 2022 | 1.29 Billion USD | -28.26% |
| 2021 | 1.8 Billion USD | -1.19% |
| 2020 | 1.82 Billion USD | 61.03% |
| 2019 | 1.13 Billion USD | 12.06% |
| 2018 | 1.01 Billion USD | 208.39% |
| 2017 | 327.6 Million USD | 4789.55% |
| 2016 | 6.7 Million USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 2.3 Million USD | -50.0% |
| 2013 | 4.6 Million USD | -32.35% |
| 2012 | 6.8 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 45.75 Million USD | -25.51% |
| 2008 | 61.42 Million USD | 0.65% |
| 2007 | 61.03 Million USD | 2781.27% |
| 2006 | 2.11 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 2.43 Billion USD | 0.07% |
| 2024 Q1 | 2.56 Billion USD | 0.07% |
| 2024 Q2 | 2.43 Billion USD | 0.07% |
| 2023 FY | 2.57 Billion USD | 99.09% |
| 2023 Q4 | 2.57 Billion USD | 2.27% |
| 2023 Q2 | 2.51 Billion USD | 86.84% |
| 2023 Q1 | 1.34 Billion USD | 4.26% |
| 2023 Q3 | 2.51 Billion USD | -0.07% |
| 2022 Q1 | 2.12 Billion USD | 17.74% |
| 2022 FY | 1.29 Billion USD | -28.26% |
| 2022 Q2 | 2.11 Billion USD | -0.21% |
| 2022 Q3 | 2.11 Billion USD | -0.24% |
| 2022 Q4 | 1.29 Billion USD | -38.79% |
| 2021 Q1 | 1.85 Billion USD | 1.72% |
| 2021 Q2 | 1.87 Billion USD | 1.13% |
| 2021 Q3 | 1.86 Billion USD | -0.59% |
| 2021 Q4 | 1.8 Billion USD | -3.37% |
| 2021 FY | 1.8 Billion USD | -1.19% |
| 2020 Q3 | 1.8 Billion USD | 4.05% |
| 2020 Q1 | 1.16 Billion USD | 2.81% |
| 2020 Q2 | 1.73 Billion USD | 48.85% |
| 2020 Q4 | 1.82 Billion USD | 1.13% |
| 2020 FY | 1.82 Billion USD | 61.03% |
| 2019 FY | 1.13 Billion USD | 12.06% |
| 2019 Q4 | 1.13 Billion USD | 3.3% |
| 2019 Q3 | 1.09 Billion USD | 2.24% |
| 2019 Q2 | 1.07 Billion USD | 0.45% |
| 2019 Q1 | 1.06 Billion USD | 5.62% |
| 2018 Q1 | 331.3 Million USD | 1.13% |
| 2018 Q3 | 346.1 Million USD | 1.11% |
| 2018 Q4 | 1.01 Billion USD | 191.91% |
| 2018 FY | 1.01 Billion USD | 208.39% |
| 2018 Q2 | 342.3 Million USD | 3.32% |
| 2017 Q2 | 327.2 Million USD | 4783.58% |
| 2017 Q4 | 327.6 Million USD | -0.94% |
| 2017 FY | 327.6 Million USD | 4789.55% |
| 2017 Q1 | 6.7 Million USD | 0.0% |
| 2017 Q3 | 330.7 Million USD | 1.07% |
| 2016 Q4 | 6.7 Million USD | 11.67% |
| 2016 FY | 6.7 Million USD | 0.0% |
| 2016 Q3 | 6 Million USD | 0.0% |
| 2016 Q2 | 6 Million USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q2 | 1.1 Million USD | -35.29% |
| 2015 Q3 | 400 Thousand USD | -63.64% |
| 2015 Q4 | - USD | -100.0% |
| 2015 FY | - USD | -100.0% |
| 2015 Q1 | 1.7 Million USD | -26.09% |
| 2014 FY | 2.3 Million USD | -50.0% |
| 2014 Q2 | 3.5 Million USD | -14.63% |
| 2014 Q3 | 2.9 Million USD | -17.14% |
| 2014 Q4 | 2.3 Million USD | -20.69% |
| 2014 Q1 | 4.1 Million USD | -10.87% |
| 2013 Q4 | 4.6 Million USD | -11.54% |
| 2013 Q3 | 5.2 Million USD | -10.34% |
| 2013 FY | 4.6 Million USD | -32.35% |
| 2013 Q2 | 5.8 Million USD | -7.94% |
| 2013 Q1 | 6.3 Million USD | -7.35% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | 6.8 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | 6.8 Million USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | 4.96 Million USD | -89.14% |
| 2010 FY | - USD | -100.0% |
| 2010 Q2 | 3.28 Million USD | -33.92% |
| 2010 Q3 | - USD | -100.0% |
| 2009 FY | 45.75 Million USD | -25.51% |
| 2009 Q3 | 44.68 Million USD | 2.33% |
| 2009 Q4 | 45.75 Million USD | 2.4% |
| 2009 Q2 | 43.66 Million USD | 2.25% |
| 2009 Q1 | 42.7 Million USD | -30.47% |
| 2008 Q1 | 62.78 Million USD | 2.88% |
| 2008 FY | 61.42 Million USD | 0.65% |
| 2008 Q2 | 62.21 Million USD | -0.91% |
| 2008 Q4 | 61.42 Million USD | -0.36% |
| 2008 Q3 | 61.65 Million USD | -0.91% |
| 2007 Q2 | 61.71 Million USD | -0.69% |
| 2007 Q4 | 61.03 Million USD | -0.56% |
| 2007 FY | 61.03 Million USD | 2781.27% |
| 2007 Q1 | 62.14 Million USD | 2834.05% |
| 2007 Q3 | 61.37 Million USD | -0.56% |
| 2006 Q2 | 1.35 Million USD | 0.0% |
| 2006 Q3 | 2.16 Million USD | 60.0% |
| 2006 FY | 2.11 Million USD | 0.0% |
| 2006 Q4 | 2.11 Million USD | -1.94% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -7026.752% |
| BrainsWay Ltd. | 239 Thousand USD | -1076427.197% |
| Cerus Corporation | 59.79 Million USD | -4202.796% |
| Envoy Medical, Inc. | 404 Thousand USD | -636756.436% |
| electroCore, Inc. | 537 Thousand USD | -479024.767% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -21440733.333% |
| IceCure Medical Ltd | 376 Thousand USD | -684181.915% |
| Inogen, Inc. | 18.27 Million USD | -13982.649% |
| OrthoPediatrics Corp. | 13.45 Million USD | -19016.576% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -1292814.573% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -707277.022% |
| MaxCyte, Inc. | 17.96 Million USD | -14218.549% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -4653868.599% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | -2663.38% |
| PAVmed Inc | 2.96 Million USD | -86822.297% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -41304.892% |
| RxSight, Inc. | 1.21 Million USD | -212360.776% |
| Sight Sciences, Inc. | 31.7 Million USD | -8014.356% |
| SI-BONE, Inc. | 36.06 Million USD | -7034.063% |
| TELA Bio, Inc. | 40.51 Million USD | -6250.487% |
| Treace Medical Concepts, Inc. | 53 Million USD | -4753.796% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -169058.448% |
| Acutus Medical, Inc. | 32.65 Million USD | -7779.28% |
| Talis Biomedical Corporation | 16.78 Million USD | -15227.654% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -63506.922% |
| CVRx, Inc. | 30.38 Million USD | -8368.501% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -252906.598% |
| Bioventus Inc. | 366.99 Million USD | -601.066% |
| Venus Concept Inc. | 70.79 Million USD | -3534.553% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -206724.759% |
| LivaNova PLC | 568.54 Million USD | -352.543% |
| 908 Devices Inc. | 3.92 Million USD | -65384.856% |
| Alphatec Holdings, Inc. | 511.03 Million USD | -403.468% |
| Nemaura Medical Inc. | 3.08 Million USD | -83228.718% |
| NeuroPace, Inc. | 56.95 Million USD | -4417.505% |
| LENSAR, Inc. | 1.75 Million USD | -146922.857% |
| Apyx Medical Corporation | 33.18 Million USD | -7653.202% |
| Cutera, Inc. | 418.69 Million USD | -514.505% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -17002.499% |
| BioSig Technologies, Inc. | 103 Thousand USD | -2497861.165% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -9463.262% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -25760.891% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | -73.257% |
| Axonics, Inc. | 25.84 Million USD | -9857.043% |
| Outset Medical, Inc. | 134.59 Million USD | -1811.587% |
| IRIDEX Corporation | 1.75 Million USD | -146838.892% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | -4911.59% |
| IRadimed Corporation | 1.61 Million USD | -159204.802% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -1461775.0% |
| INVO Bioscience, Inc. | 6.77 Million USD | -37870.292% |
| Telesis Bio, Inc. | 5.26 Million USD | -48730.898% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -42987.835% |
| Varex Imaging Corporation | 464.2 Million USD | -454.265% |
| Quipt Home Medical Corp. | 60.82 Million USD | -4130.276% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -437468.027% |
| Pulmonx Corporation | 35.08 Million USD | -7232.497% |
| Dynatronics Corporation | 3.25 Million USD | -78860.177% |
| Modular Medical, Inc. | 817 Thousand USD | -314820.441% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -1703807.285% |
| Semler Scientific, Inc. | 70 Thousand USD | -3675471.429% |
| InMode Ltd. | 6.61 Million USD | -38806.699% |
| Bruker Corporation | 1.14 Billion USD | -124.806% |
| Cytosorbents Corporation | 2.54 Million USD | -101081.466% |
| Align Technology, Inc. | 96.96 Million USD | -2553.35% |
| Viveve Medical, Inc. | 5.12 Million USD | -50112.724% |
| ZimVie Inc. | 508.79 Million USD | -405.683% |
| Movano Inc. | 15.00 USD | -17152666566.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -14095.31% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | -545.473% |
| Profound Medical Corp. | 4.97 Million USD | -51622.634% |
| Insulet Corporation | 1.36 Billion USD | -88.298% |
| enVVeno Medical Corporation | 1.06 Million USD | -241713.91% |
| Surmodics, Inc. | 29.4 Million USD | -8649.872% |
| iCAD, Inc. | 273 Thousand USD | -942354.212% |
| Nuwellis, Inc. | 221 Thousand USD | -1164108.145% |
| Biotricity, Inc. | 10.85 Million USD | -23600.623% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -7261.66% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -395882.461% |
| InspireMD, Inc. | 1.03 Million USD | -247770.906% |
| PAVmed Inc. | 2.96 Million USD | -86822.297% |
| BIOLASE, Inc. | 13.98 Million USD | -18297.569% |
| Beyond Air, Inc. | 14.72 Million USD | -17377.753% |
| FONAR Corporation | 37.92 Million USD | -6683.391% |
| AxoGen, Inc. | 46.6 Million USD | -5420.889% |
| Vivani Medical, Inc. | 19.31 Million USD | -13222.115% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | -5667.282% |
| Inari Medical, Inc. | 30.35 Million USD | -8376.034% |
| UFP Technologies, Inc. | 28 Million USD | -9088.929% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -592672.639% |
| Tenon Medical, Inc. | 428 Thousand USD | -601044.86% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -256676.447% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -119448.551% |
| AdaptHealth Corp. | 2.09 Billion USD | -22.834% |
| Sintx Technologies, Inc. | 3.68 Million USD | -69683.021% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | -6812.124% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -437468.027% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -431594.631% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | -188.363% |
| TransMedics Group, Inc. | 506.2 Million USD | -408.273% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -423771.499% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -2781864.643% |
| Hyperfine, Inc. | 64 Thousand USD | -4020056.25% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | -1263.205% |
| Biomerica, Inc. | 459 Thousand USD | -560444.662% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -572313.195% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -1354150.554% |
| Silk Road Medical, Inc | 75.62 Million USD | -3302.137% |